Michał Kaza

Michał Kaza

Auto-generated profile, based on publicly available information

Michał Kaza

Celon Pharm SA, R&D Ctr, Ul Marymoncka 15, PL-05152 Kazun Nowy, Poland

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Open access
MKMichał Kaza
Michał Kaza
Marta KarazniewiczMarta Karazniewicz
Marta Karazniewicz
Katarzyna Kosicka-NoworzyńKatarzyna Kosicka-Noworzyń
Katarzyna Kosicka-Noworzyń
ASAnna Siemiątkowska
Anna Siemiątkowska
PRPiotr J. Rudzki
Piotr J. Rudzki
Bioanalysis concerns the identification and quantification of analytes in various biological matrices. Validation of any analytical method helps to achieve reliable results that are necessary for proper decisions on drug dosing and patient safety. In the case of bioanalytical methods, validation additionally covers steps of pharmacokinetic and toxicological studies - such as sample collection, handling, shipment, storage, and preparation. We drew our attention to the difference of both the newest FDA Guidance and the EMA Guideline on bioanalytical method validation. We aimed to point out advantages of both documents from the laboratory perspective. The FDA and the EMA documents are similar, but not identical. The EMA describes the practical conduct of experiments more precisely, while the FDA presents reporting recommendations more comprehensively. There are also differences in recommended validation parameters. We hope that the International Council for Harmonisation will combine advantages of both documents to avoid confusing differences in terminology as well as the unnecessary effort of being compliant with two or more guidelines.

1 November 2008 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
JMJoanna Dorota Mankiewicz-Boczek
Joanna Dorota Mankiewicz-Boczek
GNGrzegorz Nałęcz-Jawecki
Grzegorz Nałęcz-Jawecki
ADAgata Drobniewska
Agata Drobniewska
MKM. Kaza
M. Kaza
BSBeata Sumorok
Beata Sumorok
JSJ. Sawicki
J. Sawicki

11 February 2019 in The AAPS Journal
Verified
Journal Article
Open access
PDF file
PRPiotr J. Rudzki
Piotr J. Rudzki
PBPrzemyslaw Biecek
Przemyslaw Biecek
MKMichał Kaza
Michał Kaza
Reliable results of pharmacokinetic and toxicokinetic studies are vital for correct decision making during drug discovery and development. Thus, ensuring h

19 June 2017 in Bioanalysis
Verified
Journal Article
Closed access
PRPiotr J. Rudzki
Piotr J. Rudzki
PBPrzemyslaw Biecek
Przemyslaw Biecek
MKMichał Kaza
Michał Kaza
Aim: Incurred sample reanalysis (ISR) contributes to the reliability of pharmacokinetic studies. Despite regulatory guidelines having adopted ISR methodology, graphical presentation of data has been overlooked. Materials & methods: Different graphs were tested for datasets including limited, standard and large numbers of ISR pairs. The datasets covered both passed and failed cases. Results: We have developed a combination of complementary plots enabling the visual inspection of ISR data quality: %difference versus mean concentration and cumulative ISR plot. The former shows individual ISR datapoints and concentration-dependent trends, while the latter presents the contribution of individual pairs to the overall result as well as time-dependent trends. Conclusion: The proposed visualization of ISR data shows at a glance whether acceptance criteria for each sample and whole experiment are met or not. Standardized graphical presentation of ISR outcomes may increase quality of bioanalytical data.

11 November 2015 in Biomedical Chromatography
Verified
Journal Article
Closed access
PDF file
MFMonika Filist
Monika Filist
ISIwona Szlaska
Iwona Szlaska
MKMichał Kaza
Michał Kaza
EGEdyta Gilant
Edyta Gilant

5 January 2013
Verified
Journal Article
Closed access
EGEdyta Gilant
Edyta Gilant
MKMichał Kaza
Michał Kaza
ASAnna Szlagowska
Anna Szlagowska
KSKrystyna Serafin-Byczak
Krystyna Serafin-Byczak
PRPiotr J. Rudzki
Piotr J. Rudzki